Vyking "True sales' as you put it means to you i guess, sales in...

Vyking
"True sales' as you put it means to you i guess, sales in Europe and Australia.
So whose to say the last 8 implants in 3 weeks were not in Europe?
You obviously don't think the hundreds of implants to be done during the trials in the United States are"true sales" even though the re-imbursements are one and the same.
Revenue is revenue buddy whether it's through trials or whatever.
They just finished their European and australian trials and just recently achieved permission to sell in Europe.
Yet you cry out for sales figures and implant data.
Well they are giving it to you...8 implants in 3 weeks.
I'm sure a sophisticated investor like you can work out how much revenue....yes?
And NOT every director buys shares in the companies they sit on...some sit on many.
Maybe your being a tad too critical...imho VCR are going along very nicely.
And as for the depressed shareprice all i can say is biotech stocks have been on the nose for a long time now...surely you understood that when you made your investment decision.
And for the record Pat...i hold 70k@88cents average.
And as for you making monet shorting Pat...your dreaming....that's probably why you let Challenger invest for you...lol.....nfi.